Lyell Immunopharma (LYEL) Non Operating Income: 2020-2025
Historic Non Operating Income for Lyell Immunopharma (LYEL) over the last 6 years, with Sep 2025 value amounting to -$4.9 million.
- Lyell Immunopharma's Non Operating Income fell 182.05% to -$4.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $14.0 million, marking a year-over-year increase of 6.51%. This contributed to the annual value of $15.8 million for FY2024, which is 27.35% up from last year.
- Lyell Immunopharma's Non Operating Income amounted to -$4.9 million in Q3 2025, which was down 209.04% from $4.5 million recorded in Q2 2025.
- In the past 5 years, Lyell Immunopharma's Non Operating Income registered a high of $9.2 million during Q4 2024, and its lowest value of -$36.2 million during Q4 2021.
- Moreover, its 3-year median value for Non Operating Income was $5.2 million (2025), whereas its average is $3.0 million.
- In the last 5 years, Lyell Immunopharma's Non Operating Income skyrocketed by 921.43% in 2021 and then crashed by 1,434.62% in 2022.
- Quarterly analysis of 5 years shows Lyell Immunopharma's Non Operating Income stood at -$36.2 million in 2021, then soared by 117.66% to $6.4 million in 2022, then increased by 2.99% to $6.6 million in 2023, then soared by 40.04% to $9.2 million in 2024, then slumped by 182.05% to -$4.9 million in 2025.
- Its last three reported values are -$4.9 million in Q3 2025, $4.5 million for Q2 2025, and $5.2 million during Q1 2025.